CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- 4 Planned sale CHIEF OPERATING OFFICER sold 17,300 shares at $28.28 ($489,244)
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 27,448 shares at an average $30.35 ($833,001)
- 4 Planned sale CHIEF OPERATING OFFICER sold 70,867 shares at an average $30.48 ($2,160,035)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Option exercise Director acquired 3,173 shares (option exercise)
- 4 Grant or award Director acquired 16,794 shares (grant or award)
- 4 Option exercise Director acquired 3,173 shares (option exercise)
- 4 Option exercise Director acquired 3,173 shares (option exercise)
- 4 Option exercise Director acquired 3,173 shares (option exercise)
- 4 Option exercise Director acquired 3,173 shares (option exercise)
- 4 Option exercise Director acquired 3,173 shares (option exercise)
- 4 Planned sale CHIEF ACCOUNTING OFFICER sold 15,211 shares at $28.75 ($437,316)
- 4 Planned sale CHIEF COMMERCIAL OFFICER sold 27,594 shares at $29.02 ($800,778)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 18,299 shares at $28.80 ($527,011)
- 8-K Event Regulation FD disclosure
- 144 Insider Sale of Securities
Page 9 of 39 · 778 filings